{"id":278,"date":"2025-02-12T10:54:24","date_gmt":"2025-02-12T14:54:24","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/?p=278"},"modified":"2025-02-12T10:54:24","modified_gmt":"2025-02-12T14:54:24","slug":"fda-ai-guidance-marks-a-new-era-for-biotech-diagnostics-and-regulatory-compliance","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/2025\/02\/12\/fda-ai-guidance-marks-a-new-era-for-biotech-diagnostics-and-regulatory-compliance\/","title":{"rendered":"FDA AI Guidance Marks a  New Era for Biotech, Diagnostics and Regulatory Compliance"},"content":{"rendered":"\n<p>The U.S. Food and Drug Administration\u2019s recent release of two draft guidance documents on the use of artificial intelligence in drug development, biologics and medical devices has sparked both excitement and skepticism. As AI increasingly permeates these fields, the regulatory landscape is just beginning to take shape\u2014and these proposed guidelines take a step in that direction by raising awareness of important questions about the future of AI innovation in life sciences. For therapeutic, medical device and diagnostics companies\u2014whether already implementing AI or just beginning to explore its potential\u2014the message is clear: The landscape is evolving, and future success will require thoughtful consideration of compliance, patient safety and privacy protection from the earliest stages of AI adoption.<\/p>\n\n\n\n<p>Read the full <em>Alert <\/em>on the <a href=\"https:\/\/www.duanemorris.com\/alerts\/fda_ai_guidance_new_era_biotech_diagnostics_regulatory_compliance_0225.html\">Duane Morris LLP website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration\u2019s recent release of two draft guidance documents on the use of artificial intelligence in drug development, biologics and medical devices has sparked both excitement and skepticism. As AI increasingly permeates these fields, the regulatory landscape is just beginning to take shape\u2014and these proposed guidelines take a step in that &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/artificialintelligence\/2025\/02\/12\/fda-ai-guidance-marks-a-new-era-for-biotech-diagnostics-and-regulatory-compliance\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FDA AI Guidance Marks a  New Era for Biotech, Diagnostics and Regulatory Compliance&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[18,27,21,216,77,209,203,215],"ppma_author":[5,9],"class_list":["post-278","post","type-post","status-publish","format-standard","hentry","category-general","tag-agatha-h-liu","tag-ai","tag-ai-regulation","tag-biotech","tag-fda","tag-life-sciences","tag-medtech","tag-vicki-norton"],"authors":[{"term_id":5,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""},{"term_id":9,"user_id":624,"is_guest":0,"slug":"ahliu","display_name":"Agatha H. Liu","avatar_url":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-content\/uploads\/sites\/63\/2023\/04\/liuagatha-100x100.jpg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/posts\/278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/comments?post=278"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/posts\/278\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/media?parent=278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/categories?post=278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/tags?post=278"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/artificialintelligence\/wp-json\/wp\/v2\/ppma_author?post=278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}